Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $496.66 | 23 | $0 (2024) |
| ITI, Inc. | $303.01 | 13 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $295.79 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $277.76 | 17 | $0 (2024) |
| Lundbeck LLC | $211.10 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $191.89 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $103.46 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $100.28 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $80.14 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $64.25 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,110 | 59 | Teva Pharmaceuticals USA, Inc. ($249.51) |
| 2023 | $526.02 | 23 | ITI, Inc. ($208.77) |
| 2022 | $621.37 | 25 | Teva Pharmaceuticals USA, Inc. ($179.03) |
| 2021 | $57.84 | 3 | ITI, Inc. ($34.10) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Neuropsychiatry | ||||||
| 02/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Central Nervous System | ||||||
| 02/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Central Nervous System | ||||||
| 02/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Central Nervous System | ||||||
| 02/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.85 | General |
| Category: PSYCHIATRY | ||||||
| 01/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: PSYCHIATRY | ||||||
| 01/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Neuropsychiatry | ||||||
| 01/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/08/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Central Nervous System | ||||||
| 12/01/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Neuropsychiatry | ||||||
| 12/01/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/07/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/04/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Neurology | ||||||
| 07/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 36 | $7,200 | $1,832 |
| 2022 | 2 | 31 | 77 | $17,750 | $4,918 |
| 2021 | 1 | 15 | 42 | $8,400 | $2,238 |
| 2020 | 1 | 12 | 46 | $9,200 | $1,596 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 36 | $7,200 | $1,832 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 47 | $11,750 | $3,315 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 30 | $6,000 | $1,603 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 42 | $8,400 | $2,238 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 46 | $9,200 | $1,596 | 17.3% |
About Racheal Aneke
Racheal Aneke is a Psychiatric/Mental Health healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2019. The National Provider Identifier (NPI) number assigned to this provider is 1073071684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Racheal Aneke has received a total of $2,315 in payments from pharmaceutical and medical device companies, with $1,110 received in 2024. These payments were reported across 110 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Aneke has provided services to 69 Medicare beneficiaries, totaling 201 services with total Medicare billing of $10,584. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Riverside, CA
- Active Since 03/04/2019
- Last Updated 01/22/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1073071684
Products in Payments
- REXULTI (Drug) $397.91
- CAPLYTA (Drug) $383.15
- INGREZZA (Drug) $295.79
- INVEGA SUSTENNA (Drug) $191.89
- AUSTEDO (Drug) $179.03
- Austedo XR (Drug) $174.09
- UZEDY (Drug) $143.54
- Auvelity (Drug) $103.46
- COBENFY (Drug) $81.67
- ABILIFY ASIMTUFII (Drug) $73.82
- LOREEV XR (Drug) $56.23
- HETLIOZ (Drug) $47.09
- TRINTELLIX (Drug) $46.57
- Azstarys (Drug) $34.88
- Dyanavel XR (Drug) $33.22
- Xelstrym (Drug) $19.86
- FANAPT (Drug) $17.16
- ABILIFY MAINTENA (Drug) $17.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Riverside
Mr. Samuel Kaufman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $17,573
Quiana Cooper, Np, NP
Psychiatric/Mental Health — Payments: $4,889
Ms. Britni Turano, Ms Rn Pmhnp-Bc, MS RN PMHNP-BC
Psychiatric/Mental Health — Payments: $4,799
Deep Patel
Psychiatric/Mental Health — Payments: $4,551
Mr. Sukh Dev Singh Khalsa, P.m.h.n.p, P.M.H.N.P
Psychiatric/Mental Health — Payments: $3,033
Jessica Millan, Np, NP
Psychiatric/Mental Health — Payments: $2,235